Abstract:Chronic viral infections where the antigen persists long-term, induces an exhaustion phenotype in responding T cells. It is now evident that immune checkpoints on T cells including PD-1, CTLA-4, and PSGL-1 ( Selplg ) are linked with the differentiation of exhausted cells. Chronic T cell receptor signaling induces transcriptional signatures that result in the development of various exhausted T cell subsets, including the stem-like T cell precursor exhausted (Tpex) cells, which can be reinvigorated by immune checkpoint inhibitors (ICIs). While PSGL-1 has been shown to inhibit T cell responses in various disease models, the cell-intrinsic function of PSGL-1 in the differentiation, maintenance, and reinvigoration of exhausted T cells is unknown. We found Selplg -/- T cells had increased expansion in melanoma tumors and in early stages of chronic viral infection. Despite their increase, both WT and Selplg -/- T cells eventually became phenotypically and functionally exhausted. Even though virus-specific Selplg -/- CD4 + and CD8 + T cells were increased at the peak of T cell expansion, they decreased to lower levels than WT T cells at later stages of chronic infection. We found that Selplg -/- CD8 + Tpex (SLAMF6 hi TIM3 lo , PD-1 + TIM3 + , TOX + , TCF-1 + ) cell frequencies and numbers were decreased compared to WT T cells. Importantly, even though virus-specific Selplg -/- CD4 + and CD8 + T cells were lower, they were reinvigorated more effectively than WT T cells after anti-PD-L1 treatment. We found increased SELPLG expression in Hepatitis C-specific CD8 + T cells in patients with chronic infection, whereas these levels were decreased in patients that resolved the infection. Together, our findings showed multiple PSGL-1 regulatory functions in exhausted T cells. We found that PSGL-1 is a cell-intrinsic inhibitor that limits T cells in tumors and in persistently infected hosts. Additionally, while PSGL-1 is linked with T cell exhaustion, its expression was required for their long-term maintenance and optimal differentiation into Tpex cells. Finally, PSGL-1 restrained the reinvigoration potential of exhausted CD4 + and CD8 + T cells during ICI therapy. Our findings highlight that targeting PSGL-1 may have therapeutic potential alone or in combination with other ICIs to reinvigorate exhausted T cells in patients with chronic infections or cancer.

mTOR signals regulate T cell exhaustion and T cell responses during PD-1 targeted immunotherapy in chronic viral infection.

Restoring function in exhausted CD8 T cells during chronic viral infection

Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade

CD40 Agonist Converting CTL Exhaustion Via the Activation of the Mtorc1 Pathway Enhances PD-1 Antagonist Action in Rescuing Exhausted CTLs in Chronic Infection.

CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy

PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors

Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control

TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells

Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion

PD-1 combination therapy with IL-2 modifies CD8 + T cell exhaustion program

Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

PD-1 immune checkpoint blockade can synergize with PSGL-1 inhibition to reinvigorate exhausted T cells

Strength of PD-1 Signaling Differentially Affects T-cell Effector Functions

PD-1 controls differentiation, survival, and TCR affinity evolution of stem-like CD8+ T cells

CD8+ T Cells Mediate Lethal Lung Pathology in the Absence of PD-L1 and Type I Interferon Signalling following LCMV Infection

PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells

Dichotomous regulation of progenitor-like CD8 T cells during chronic viral infection by TCF1 and type I interferon

Reversing T-cell Dysfunction and Exhaustion in Cancer

PD-1 and LAG-3: synergistic fostering of T cell exhaustion